Lawyers for Risperdal Breast Growth in Male Children

The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential lawsuits on behalf of boys who developed breasts after Risperdal use, suffering a condition known as gynecomastia.

Contact Our Lawyers to Review anRISPERDAL LAWSUIT

  • This field is for validation purposes and should be left unchanged.

*By submitting, you authorize Saiontz & Kirk, P.A. to send text messages to the numbers provided, including information & offers, possibly using automated technology. Message/data rates apply. Consent is not a condition for acceptance of services.
Saiontz & Kirk, PA, Attorneys & Lawyers, Baltimore, MD

Millions in damages have been awarded by juries over the drug maker’s failure to adequately warn about this serious and devastating side effect, and additional individuals may be entitled to financial compensation through a Risperdal breast growth lawsuit.

Potential claims are being reviewed for boy children diagnosed with gynecomastia or male breasts after using Risperdal. Problems may result in:

  • Breast Growth Among Boys
  • Puffy Nipples or Enlarged Nipples
  • Painful Breasts or Nipple Discharge
  • Mastectomy or Gynecomastia Surgery to Remove Male Breasts

All cases are reviewed by our Risperdal lawyers on a contingency fee basis, which means there are no fees or expenses unless a recovery is obtained. To review a potential case for yourself, your child or family member, request a free consultation and claim evaluation.


Risperdal (risperidone) is an atypical antipsychotic manufactured and sold by Johnson & Johnson, which was originally approved by the FDA for use among adults with schizophrenia. Since it was introduced, Risperdal has been widely used by children for bi-polar disorders, autism, irritability, aggression and behavior disorders.

Known side effects of Risperdal include an increased risk of weight gain, which may cause doctors to fail to recognize or diagnose male breast growth among children.

A number of male children on Risperdal have suffered gynecomastia, which involves the abnormal development of large mammary glands among boys and adolescents, resulting in breast development.

These Risperdal problems may be caused by an increase in the amount of the hormone prolactin in the blood caused by the drug. Prolactin induces and maintains lactation among women following childbirth, and may cause boys to develop gynecomastia from Risperdal.

In many cases, surgery is necessary to remove the breasts caused by the Risperdal gynecomastia side effects. In addition to the physical pain and suffering, this may cause emotional trauma for boys and young adult males who experience problems.


A growing number of families throughout the United States are pursuing a Risperdal lawsuit on behalf of kids and young adults who developed breasts on Risperdal.

Lawsuits allege that Johnson & Johnson failed to adequately research the effects of their medication or warn about the connection between Risperdal and breast growth.

Before it became available as a generic in 2008, Risperdal was a blockbuster medication, generating global sales of $4.5 billion in 2007. However, Johnson & Johnson has faced substantial legal problems over their Risperdal promotions, which illegally marketed the drug for off-label uses that were never approved or established as safe and effective.

Several early “bellwether” Risperdal trials have resulted substantial damage awards after juries evaluated the evidence, including one verdict of $70 million awarded to the family of a five year old boy who developed breasts following use of the medication.

While Johnson & Johnson has reached a small number of Risperdal settlements to resolve some cases before they reached a jury, additional time still remains for families and adult males with breast growth from Risperdal to pursue financial compensation.


It appears that the drug maker put their desire for profits before the safety of young boys using Risperdal, failing to adequately warn about the potential breast growth problems that may be experienced from use of the antipsychotic.

The attorneys at Saiontz & Kirk, P.A. are providing free consultations and claim evaluations to help determine whether former users may be entitled to financial compensation through an individual case and Risperdal class action lawsuit.

All claims are pursued under a contingency fee agreement, which means that there are no out-of-pocket expenses to hire our lawyers and we receive no attorneys fees unless we are successful with the case.